[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Halozyme Therapeutic (HALO)

Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,892,509
  • Shares Outstanding, K 118,613
  • Annual Sales, $ 1,397 M
  • Annual Income, $ 316,890 K
  • EBIT $ 649 M
  • EBITDA $ 741 M
  • 60-Month Beta 0.89
  • Price/Sales 5.79
  • Price/Cash Flow 14.29
  • Price/Book 36.78

Options Overview Details

View History
  • Implied Volatility 33.94% (+2.11%)
  • Historical Volatility 32.39%
  • IV Percentile 15%
  • IV Rank 19.46%
  • IV High 52.70% on 08/05/25
  • IV Low 29.41% on 06/16/25
  • Expected Move (DTE 19) 4.59 (6.90%)
  • Put/Call Vol Ratio 0.10
  • Today's Volume 413
  • Volume Avg (30-Day) 1,317
  • Put/Call OI Ratio 0.35
  • Today's Open Interest 17,549
  • Open Int (30-Day) 15,895
  • Expected Range 61.95 to 71.13

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $1.73
  • Number of Estimates 3
  • High Estimate $1.78
  • Low Estimate $1.67
  • Prior Year $1.47
  • Growth Rate Est. (year over year) +17.69%

Price Performance

See More
Period Period Low Period High Performance
1-Month
62.38 +6.67%
on 05/01/26
73.89 -9.95%
on 05/12/26
+3.48 (+5.52%)
since 04/29/26
3-Month
61.33 +8.50%
on 03/27/26
73.89 -9.95%
on 05/12/26
-2.99 (-4.30%)
since 02/27/26
52-Week
51.06 +30.32%
on 06/30/25
82.22 -19.07%
on 02/09/26
+12.11 (+22.25%)
since 05/28/25

Most Recent Stories

More News
Halozyme Therapeutics’s Q1 Earnings Call: Our Top 5 Analyst Questions

Halozyme Therapeutics’s Q1 Earnings Call: Our Top 5 Analyst Questions

HALO : 66.54 (-2.41%)
3 Growth Stocks Set to Flourish

3 Growth Stocks Set to Flourish

CECO : 74.75 (-10.27%)
TOST : 26.03 (+4.29%)
HALO : 66.54 (-2.41%)
Thermo Fisher, Dentsply Sirona, Collegium Pharmaceutical, and Halozyme Therapeutics Stocks Trade Down, What You Need To Know

Thermo Fisher, Dentsply Sirona, Collegium Pharmaceutical, and Halozyme Therapeutics Stocks Trade Down, What You Need To Know

COLL : 33.61 (+0.72%)
TMO : 492.51 (+1.09%)
XRAY : 10.47 (+1.75%)
HALO : 66.54 (-2.41%)
Therapeutics Stocks Q1 Recap: Benchmarking Halozyme Therapeutics (NASDAQ:HALO)

Therapeutics Stocks Q1 Recap: Benchmarking Halozyme Therapeutics (NASDAQ:HALO)

HALO : 66.54 (-2.41%)
HALO Q1 Deep Dive: Royalty Expansion and Pipeline Progress Shape 2026 Outlook

HALO Q1 Deep Dive: Royalty Expansion and Pipeline Progress Shape 2026 Outlook

HALO : 66.54 (-2.41%)
Halozyme Therapeutics Q1 Earnings Call Highlights

Halozyme Therapeutics (NASDAQ:HALO) reported a sharp increase in first-quarter 2026 revenue and earnings, driven by continued growth in royalties from its ENHANZE drug-delivery platform, and announced...

HALO : 66.54 (-2.41%)
Halozyme Therapeutics: Q1 Earnings Snapshot

Halozyme Therapeutics: Q1 Earnings Snapshot

HALO : 66.54 (-2.41%)
Halozyme Therapeutics’s (NASDAQ:HALO) Q1 CY2026 Sales Top Estimates

Halozyme Therapeutics’s (NASDAQ:HALO) Q1 CY2026 Sales Top Estimates

HALO : 66.54 (-2.41%)
HALOZYME REPORTS FIRST QUARTER 2026 RESULTS AND REITERATES 2026 FINANCIAL GUIDANCE

Announcing New $1 billion Share Repurchase Program Projecting to Buy Back at Least $400 million in 2026

HALO : 66.54 (-2.41%)
Halozyme: A Decade of Platform Revenue Finally Gets Its First Real Stress Test

Barchart Research What to Expect from HALO Earnings HALO Generated May 8, 2026 Current Price $64.12 EPS Estimate $$1.46 Consensus Rating Moderate Buy Average Move 6.47% Halozyme: A Decade of Platform Revenue...

HALO : 66.54 (-2.41%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed below 50%. The market is indicating support for a bearish trend.

See More Share

Business Summary

Halozyme Therapeutics Inc. is a biopharmaceutical company, focused on the development and commercialization of novel treatments for oncology indications by targeting tumor microenvironment. The company's ENHANZE drug delivery technology helps in developing subcutaneous formulation of drugs. The company...

See More

Key Turning Points

3rd Resistance Point 70.19
2nd Resistance Point 69.41
1st Resistance Point 67.97
Last Price 66.54
1st Support Level 65.75
2nd Support Level 64.97
3rd Support Level 63.53

See More

52-Week High 82.22
Fibonacci 61.8% 70.32
Fibonacci 50% 66.64
Last Price 66.54
Fibonacci 38.2% 62.96
52-Week Low 51.06

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.